VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 62 filers reported holding VOR BIOPHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $794,394 | -31.4% | 374,714 | 0.0% | 1.79% | -9.5% |
| Q2 2023 | $1,157,866 | -42.6% | 374,714 | 0.0% | 1.98% | -50.9% |
| Q1 2023 | $2,015,961 | -19.1% | 374,714 | 0.0% | 4.02% | -1.1% |
| Q4 2022 | $2,491,848 | +67.1% | 374,714 | 0.0% | 4.07% | +75.2% |
| Q3 2022 | $1,491,000 | -19.9% | 374,714 | 0.0% | 2.32% | -9.4% |
| Q2 2022 | $1,862,000 | -17.7% | 374,714 | 0.0% | 2.56% | +48.8% |
| Q1 2022 | $2,263,000 | -48.0% | 374,714 | 0.0% | 1.72% | -12.2% |
| Q4 2021 | $4,354,000 | – | 374,714 | – | 1.96% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 6,692,429 | $124,814,000 | 31.41% |
| Trustees of Columbia University in the City of New York | 183,821 | $3,428,000 | 5.06% |
| RA Capital Management | 11,120,973 | $207,406,000 | 3.33% |
| Johnson & Johnson Innovation - JJDC, Inc. | 1,074,658 | $20,042,000 | 2.05% |
| Sarissa Capital Management LP | 707,010 | $13,186,000 | 1.05% |
| SECTORAL ASSET MANAGEMENT INC | 405,324 | $7,559,000 | 0.61% |
| Woodline Partners LP | 1,146,494 | $21,382,000 | 0.40% |
| Artal Group S.A. | 550,000 | $10,258,000 | 0.21% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 50,000 | $933,000 | 0.20% |
| Orbimed Advisors | 833,333 | $15,542,000 | 0.16% |